LINDEN, N.J., Feb. 26, 2019 /PRNewswire/ -- PIC Corporation has entered into an exclusive license and distribution agreement with ICB Pharma. Nitolic® Head Lice and Nits Treatment Kit kills all active development stages of head lice in a single 60 minute treatment. It is 100% pesticide free and effective on insecticide resistant lice (Super Lice).
"PIC® has over 65 years of experience in helping families solve their pest problems both inside and outside their homes," states CEO Eric Rubel. "We believe that providing individuals with a simple, pesticide free solution to eradicate headlice is just another way we can help. We have also decided to donate a portion of the proceeds to Anti-Bullying Organizations as people are stigmatized by contracting lice."
ICB Pharma is a European research and production company based on long-lasting tradition and innovative approach. The company is a specialist with over 25 years of experience in head lice treatment. ICB Pharma offers original solutions with great practical values based on advanced technologies. Its products are associated with safe use as well as the highest standards of quality.
Nitolic® is helping children and their parents in 23 countries to fight the head lice problem. The brand is conquering new markets and expanding its range due to high efficacy, safety and easy application.
SOURCE PIC Corporation
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article